$BNGO “Bionano Genomics Continues to See Expansion in the Adoption of Saphyr.” A few months ago, in an email exchange, Erik told me that what the industry is looking at is adoptions of Saphyr. He said that the decision makers need confirmation that other people value Saphyr before they will come aboard. So it’s like a snowball, the more adoptions , the faster adoptions will grow. Erik also emphasized that it is adoptions, and the rate of new adoptions, that will be a key in formulating an acquisition price offer, not sales. He said that it is assumed that sales—which lag adoptions by a considerable time—will follow from adoptions.